Dies ist eine Übersichtsseite mit Metadaten zu dieser wissenschaftlichen Arbeit. Der vollständige Artikel ist beim Verlag verfügbar.
Mitogen-Activated Protein Kinase Pathways Mediated by ERK, JNK, and p38 Protein Kinases
4.281
Zitationen
2
Autoren
2002
Jahr
Abstract
Multicellular organisms have three well-characterized subfamilies of mitogen-activated protein kinases (MAPKs) that control a vast array of physiological processes. These enzymes are regulated by a characteristic phosphorelay system in which a series of three protein kinases phosphorylate and activate one another. The extracellular signal-regulated kinases (ERKs) function in the control of cell division, and inhibitors of these enzymes are being explored as anticancer agents. The c-Jun amino-terminal kinases (JNKs) are critical regulators of transcription, and JNK inhibitors may be effective in control of rheumatoid arthritis. The p38 MAPKs are activated by inflammatory cytokines and environmental stresses and may contribute to diseases like asthma and autoimmunity.
Ähnliche Arbeiten
Mutations of the BRAF gene in human cancer
2002 · 10.646 Zit.
The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity
2012 · 8.451 Zit.
Combined Nivolumab and Ipilimumab or Monotherapy in Untreated Melanoma
2015 · 8.097 Zit.
Improved Survival with Vemurafenib in Melanoma with BRAF V600E Mutation
2011 · 7.677 Zit.
Pembrolizumab versus Ipilimumab in Advanced Melanoma
2015 · 5.811 Zit.